Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › cilostazol

cilostazol

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of cilostazol

9 trials tracked of cilostazol: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 140 citations.

9Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 6 Phase 3 1 Phase 1 1 Other / NA 1
  1. Phase 3 LACunar Intervention (LACI-2) Trial-2 Completed · 140 cited
  2. Phase 4 Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II Completed
  3. Phase 4 Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2) Completed
  4. Phase 4 Cilostazol Augmentation Study in Dementia Completed
  5. Phase 4 Effect of Cilostazol in the Acute Lacunar Infarction Based on Pulsatility Index of Transcranial Doppler Completed
  6. Phase 4 Evaluation of Cilostazol in Combination With L-Carnitine Completed
Show 3 more trials
  1. Phase 4 Overcome Biochemical Aspirin Resistance Through Cilostazol Combination Completed
  2. Phase 1 Pharmacodynamic Study of Cilostazol in Healthy Volunteers Completed
  3. N/A Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Isosorbide mononitrate reduces composite events (OR 0.74) in patients with lacunar stroke
Neurology RCT
Isosorbide mononitrate reduces composite events (OR 0.74) in patients with lacunar stroke Trial Shows Isosorbide Mononitrate Reduces Risks After Lacunar Stroke
This Phase 2b randomized trial of 363 participants with lacunar stroke found that isosorbide mononitrate reduced the risk of a composite out…
A new clinical trial suggests that isosorbide mononitrate may reduce serious complications and improve mood for patients following a lacunar…
Aug 9, 2026
VerifyNow-guided antiplatelet modification linked to lower stroke recurrence in atherothrombotic or lacunar infarction
Neurology RCT
VerifyNow-guided antiplatelet modification linked to lower stroke recurrence in atherothrombotic or lacunar infarction Testing Blood Saves Stroke Patients From Recurrence
A retrospective observational study of 243 patients with atherothrombotic or lacunar infarction found that VerifyNow-guided antiplatelet the…
Doctors who adjusted blood thinner choices based on a simple blood test saw far fewer repeat strokes in patients with prior clots.
medRxiv Apr 16, 2026
Post hoc analysis finds cilostazol reduces stroke recurrence without lowering systolic blood pressure
Neurology RCT
Post hoc analysis finds cilostazol reduces stroke recurrence without lowering systolic blood pressure Study finds cilostazol reduces stroke recurrence without lowering blood pressure
A post hoc mediation analysis of an RCT in 1,795 patients with noncardioembolic ischemic stroke found dual therapy with cilostazol plus…
Cilostazol lowers stroke recurrence risk in patients with prior noncardioembolic strokes without working by dropping their blood pressure.
Apr 3, 2026